
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 4 March 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 3MB, 220 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
“Ischemic Stroke and Transient Ischemic Attack Risk Following Vitamin K Antagonist Cessation in Newly Diagnosed Atrial Fibrillation: A Cohort Study”, J Am Heart Assoc, vol. 9, p. e014376, 2020.
, “Prediction of significant bleeding during vitamin K antagonist treatment for venous thromboembolism in outpatients”, Br J Haematol, 2020.
, “Variation in the Association between Antineoplastic Therapies and Venous Thromboembolism in Patients with Active Cancer”, Thromb Haemost, vol. 120, pp. 847-856, 2020.
, “Incidence of Lyme disease in the UK: a population-based cohort study”, BMJ Open, vol. 9, p. e025916, 2019.
, , “Therapy persistence in newly diagnosed non-valvular atrial fibrillation treated with warfarin or NOAC. A cohort study”, Thromb Haemost, vol. 115, pp. 31-9, 2016.
, “Incidence rates of clinically significant tinnitus: 10-year trend from a cohort study in England”, Ear Hear, vol. 36, pp. e69-75, 2015.
, “Increasing incidence of non-valvular atrial fibrillation in the UK from 2001 to 2013”, Heart, vol. 101, pp. 1748-54, 2015.
,